Cognitive Multisensory Rehabilitation for CRPS Treatment
1 other identifier
interventional
4
1 country
1
Brief Summary
Pain treatment for Complex Regional Pain Syndrome (CRPS) is challenging. There is some evidence that pain can be reduced by therapies aimed at helping patients 'find' normal sensation in the painful body part (i.e. perceiving the exact location of a touch on the painful hand with eyes closed). In this study, a collaboration between the CRPS service at Royal United Hospital (RUH), University of the West of England (UWE), University of Bath (UoB) and Cognitive Multisensory Rehabilitation Center, the investigators aim to test whether it is possible to administer a treatment called Cognitive Multisensory Rehabilitation (CMR) to people with CRPS. In order to do this, treatment-partners (e.g. spouses, partners) will be trained to deliver CMR in a home-based environment under the supervision of a CMR specialist. Generally speaking, CMR is a rehabilitation technique in which patients are guided to better feel their painful limb by paying more attention to different sensations (e.g. touch, or position), and mindfully moving it. Since previously CMR has shown promising results in people with stroke, the investigators believe that this method could be very useful for treating pain in CRPS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 13, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedNovember 27, 2024
September 1, 2024
1.8 years
August 13, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of sessions (number of total sessions), duration (total duration of intervention in minutes), frequency (number of sessions over 4 weeks), presence of any exacerbation of symptoms (number total of symptom exacerbation).
Suitability
Pre-post intervention (4 weeks)
Number of sessions (number of total sessions), duration (total duration of intervention in minutes), frequency (number of sessions over 4 weeks), presence of any exacerbation of symptoms (number total of symptom exacerbation).
Feasibility
Pre-post intervention (4 weeks)
Secondary Outcomes (7)
Neuropathic Pain Symptom Inventory (ranging from 0-100, higher score indicates worse outcome)
Pre-post intervention (4 weeks)
Tampa Scale of Kinesiophobia (ranging from 17-68, higher score indicates worse outcome)
Pre-post intervention (4 weeks)
The Bath CRPS body perception disturbance scale (ranging from 0-57, higher score indicate worse outcome)
Pre post intervention (4 weeks)
Evaluation of Daily Activity Questionnaire (ranging from 0-147, higher scores indicate worse outcome)
Pre post intervention (4 weeks)
EQ-5D-5L (0-100, higher value indicates better outcome)
Pre post intervention (4 weeks)
- +2 more secondary outcomes
Study Arms (1)
CMR intervention
EXPERIMENTALParticipants receive CMR intervention delivered by a treatment partner in a home enviornment
Interventions
CMR targets somatosensory and multisensory and cognitive functions through sensory discrimination exercises.
Eligibility Criteria
You may qualify if:
- Participants meet the Budapest criteria for Type I CRPS4 (i.e. the diagnostic criteria for CRPS) in one limb (unilateral).
- Pain duration for a minimum of 3 months.
- years in age or older.
- Able to understand verbal and written English.
- Willing to participate and provide written informed consent.
- Have not previously received CMR.
- Have someone available to act as treatment facilitator and consent to participate in the study.
You may not qualify if:
- Presence of any co-morbidity that may influence CRPS symptoms including stroke, diabetic peripheral neuropathy, progressive neurological disease such as multiple sclerosis, and Parkinson's disease.
- Presence of Post-Traumatic Stress Disorder or other psychological conditions hindering patients' ability to engage with the intervention.
- Serious ill health.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal United Hospital
Bath, BA1 3NG, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jane Carter, Head
Royal United Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 13, 2024
First Posted
September 19, 2024
Study Start
February 1, 2023
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
November 27, 2024
Record last verified: 2024-09